Gilead Sciences (GILD) Cash from Investing Activities (2016 - 2025)
Gilead Sciences (GILD) has disclosed Cash from Investing Activities for 17 consecutive years, with -$1.8 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities fell 715.56% year-over-year to -$1.8 billion, compared with a TTM value of -$4.8 billion through Dec 2025, down 38.97%, and an annual FY2025 reading of -$4.8 billion, down 38.97% over the prior year.
- Cash from Investing Activities was -$1.8 billion for Q4 2025 at Gilead Sciences, down from -$427.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$225.0 million in Q4 2024 and bottomed at -$2.2 billion in Q1 2024.
- Average Cash from Investing Activities over 5 years is -$805.2 million, with a median of -$530.0 million recorded in 2021.
- The sharpest move saw Cash from Investing Activities surged 96.9% in 2021, then tumbled 715.56% in 2025.
- Year by year, Cash from Investing Activities stood at -$278.0 million in 2021, then crashed by 34.89% to -$375.0 million in 2022, then crashed by 93.87% to -$727.0 million in 2023, then surged by 69.05% to -$225.0 million in 2024, then crashed by 715.56% to -$1.8 billion in 2025.
- Business Quant data shows Cash from Investing Activities for GILD at -$1.8 billion in Q4 2025, -$427.0 million in Q3 2025, and -$2.1 billion in Q2 2025.